Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Grifols SA (GRFS)
NASDAQ:GRFS
Holding GRFS?
Track your performance easily
GRFS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.30 - $12.15
Previous Close$9.24
Volume570.43K
Average Volume (3M)1.78M
Market Cap
$6.87B
Enterprise Value$21.14B
Total Cash (Recent Filing)€553.22M
Total Debt (Recent Filing)€11.07B
Price to Earnings (P/E)36.8
Beta1.67
Next Earnings
Nov 07, 2024EPS Estimate
$0.25Last Dividend Ex-Date
Jun 03, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.25
Shares Outstanding687,554,908
10 Day Avg. Volume828,354
30 Day Avg. Volume1,776,674
Standard Deviation0.12
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.09
Price to Sales (P/S)3.26
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$17.19Price Target Upside92.28% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Grifols SA News
Ownership Overview
0.00%
Insiders
10.41% Mutual Funds
38.31% Other Institutional Investors
51.28% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GRFS FAQ
What was Grifols SA’s price range in the past 12 months?
Grifols SA lowest stock price was $5.30 and its highest was $12.15 in the past 12 months.
What is Grifols SA’s market cap?
Currently, no data Available
When is Grifols SA’s upcoming earnings report date?
Grifols SA’s upcoming earnings report date is Nov 07, 2024 which is in 50 days.
How were Grifols SA’s earnings last quarter?
Grifols SA released its earnings results on Jul 30, 2024. The company reported $0.024 earnings per share for the quarter, missing the consensus estimate of $0.146 by -$0.122.
Is Grifols SA overvalued?
According to Wall Street analysts Grifols SA’s price is currently Undervalued.
Does Grifols SA pay dividends?
Grifols SA pays a Annually dividend of $0.34 which represents an annual dividend yield of N/A. See more information on Grifols SA dividends here
What is Grifols SA’s EPS estimate?
Grifols SA’s EPS estimate is $0.25.
How many shares outstanding does Grifols SA have?
Grifols SA has 261,425,100 shares outstanding.
What happened to Grifols SA’s price movement after its last earnings report?
Grifols SA reported an EPS of $0.024 in its last earnings report, missing expectations of $0.146. Following the earnings report the stock price went up 0.519%.
Which hedge fund is a major shareholder of Grifols SA?
Among the largest hedge funds holding Grifols SA’s share is Brandes Investment Partners LP. It holds Grifols SA’s shares valued at 117M.
---
Grifols SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$17.19 (92.28% Upside)
$17.19 (92.28% Upside)
Blogger Sentiment
Neutral
GRFS Sentiment 67%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 2.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 10.7%
Last 30 Days ▲ 10.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-6.57%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
2.17%
Trailing 12-Months
Company Description
Grifols SA
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
---
GRFS Company Deck
---
GRFS Earnings Call
Q2 2024
0:00 / 0:00
---
GRFS Stock 12 Month Forecast
Average Price Target
$17.19
▲(92.28% Upside)
Technical Analysis
Best Analysts Covering GRFS
1 Year
1 Year Success Rate
2/8 ratings generated profit
1 Year Average Return
-7.58%
reiterated a buy rating 2 months ago
Copying Tom Jones's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -7.58% per trade.
---